Azra Pharmaceuticals Private Limited
About Azra Pharmaceuticals Private Limited
Data last updated:
Azra Pharmaceuticals Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51507UP2018PTC101753. Its GSTIN is 20AAQCA6111M2ZQ (Jharkhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Rakhi Kumari Singh and Ramesh Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at N 548 Sector 25, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2022, the company reported a revenue of ₹2.59 Lakh. For the same year it recorded a net profit of ₹4,127 (net margin 1.6%) and EBITDA of ₹6,127 (EBITDA margin 2.4%). Revenue has declined at a compounded annual rate (CAGR) of 34% over three years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Company details
Contact details
Azra Pharmaceuticals Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressN 548 Sector 25, Noida, Uttar Pradesh, India – 201301
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Azra Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Azra Pharmaceuticals Private Limited
FY 2022 filings availableAzra Pharmaceuticals Private Limited reported revenue of ₹2.59 Lakh for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 34% over three years. EBITDA rose 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6,127 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,127 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Azra Pharmaceuticals Private Limited, buy the company report.
Board of directors of Azra Pharmaceuticals Private Limited
Azra Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakhi Kumari Singh | Director | 01 Sep 2021 | 5 Years 2 Months | Current |
| Ramesh Kumar Singh | Director | 08 Mar 2018 | 8 Years 7 Months | Current |
Auditor
Azra Pharmaceuticals Private Limited is audited by ANUP & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANUP & CO | FY 2020 | 325856E |
Shareholding
The shareholding of Azra Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Azra Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Mar 2019 | 100259746 | Bank of India | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Azra Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Azra Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Azra Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAQCA6111M2ZQ | Jharkhand | Active | 05 May 2022 |
To see the full GST registrations and return filing status of Azra Pharmaceuticals Private Limited, buy the company report.
Recent activity
Azra Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Ajit Kumar Singh ceased to be Director on 01 Apr 2022.
Frequently asked questions
Azra Pharmaceuticals is an active private limited company based in Noida, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 March 2018 (8+ years old) and is registered under CIN U51507UP2018PTC101753.
Azra Pharmaceuticals has 2 current directors:
- Rakhi Kumari Singh - Director
- Ramesh Kumar Singh - Director
The latest financial statements of Azra Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Azra Pharmaceuticals is 20AAQCA6111M2ZQ, registered in Jharkhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Azra Pharmaceuticals is U51507UP2018PTC101753. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Azra Pharmaceuticals was incorporated on 08 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Ajit Kumar Singh ceased to be Director on 01 Apr 2022. Rakhi Kumari Singh was appointed as Director on 01 Sep 2021. Ramesh Kumar Singh was appointed as Director on 08 Mar 2018.
The registered office of Azra Pharmaceuticals is at N 548 Sector 25, Noida, Uttar Pradesh, India – 201301.
Azra Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Azra Pharmaceuticals has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
